JP Patent

JP6688352B2 — 補体媒介障害の治療のためのアリール化合物、ヘテロアリール化合物及び複素環式化合物

Assigned to アキリオン ファーマシューティカルズ，インコーポレーテッド · Expires 2020-04-28 · 6y expired

What this patent protects

Patent listed against danicopan.

Drugs covered by this patent

Patent Metadata

Patent number
JP6688352B2
Jurisdiction
JP
Classification
—
Expires
2020-04-28
Drug substance claim
No
Drug product claim
No
Assignee
アキリオン ファーマシューティカルズ，インコーポレーテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.